As per the Letter attached
Awaiting price reaction for this filing.
BSE's Surveillance Team flagged an unusual increase in the trading volume of Sai Life Sciences shares and asked the company to explain. Sai Life Sciences responded that the volume rise is purely market-driven and not due to any company-specific event. The company confirmed it is in compliance with SEBI's Listing Obligations and Disclosure Requirements (Regulation 30). It also stated there are no pending material announcements or undisclosed events that could explain the price/volume movement.
This is a routine exchange query with a neutral response — the company is attributing the volume spike to general market activity rather than any corporate development. Investors should note that no new fundamental trigger has been disclosed, so the movement likely reflects broader market or sector-level interest rather than company-specific news.